This inventor holds 1 USPTO granted patent. Top assignee: Industrial Technology Research Institute. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Nai-Yun Hsu: Innovator in Herbal Pharmaceutical Compositions
Introduction
Nai-Yun Hsu is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in treating allergic disorders. His innovative approach combines traditional herbal remedies with modern scientific methods.
Latest Patents
Nai-Yun Hsu holds a patent for an "Herbal composition for treating allergic disorders and method for making the same." This patent describes pharmaceutical compositions that include alcohol extracts of herbal plants. The manufacturing process involves novel procedures such as decocting with specific alcohol concentrations, filtering, regulating pH, purifying, concentrating, and creating granule powder from lyophilized extracts. The invention has been evaluated through both in vitro and in vivo assays, demonstrating its therapeutic effects. The combination of herbal extracts maximizes anti-inflammatory activity and regulates cytokine secretion, which is crucial for treating conditions like asthma.
Career Highlights
Nai-Yun Hsu is affiliated with the Industrial Technology Research Institute, where he continues to advance research in pharmaceutical innovations. His work focuses on developing effective treatments for immunological disorders, showcasing his commitment to improving health outcomes.
Collaborations
He collaborates with notable colleagues, including Rong-Ming Lyu and I-Hong Pan, to further enhance the research and development of herbal pharmaceutical compositions.
Conclusion
Nai-Yun Hsu's contributions to the field of herbal medicine and pharmaceutical compositions highlight the potential of integrating traditional knowledge with modern science. His innovative patent serves as a testament to his dedication to improving treatments for allergic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
